Kurt Pike
Senior Director - External Innovation Johnson & Johnson
Kurt is a highly experienced Drug Hunter and Medicinal Chemist with over 20 years’ experience leading drug discovery teams to deliver 9 molecules into human trials, and almost 10 years’ experience in BD / External Innovation roles. Kurt is a Senior Director in the J&J Innovative Medicines External Innovation team supporting the Discovery and Development organisation where his role involves working with Entrepreneurs and Innovators to identify future collaboration opportunities, aligned with J&J’s strategic focus, to bring forward innovative new therapies to transform human health. Kurt is an author on >40 peer-reviewed publications and an inventor on ~40 patents.
Seminars
Wednesday 2nd December 2026
Panel Discussion: Why Are Big Pharma Betting on Targeted Radiopharmaceuticals?
5:00 pm
- Exploring the scientific, clinical and commercial factors driving increasing investment into targeted radiopharmaceuticals from large pharmaceutical companies
- Comparing the evolution of the radiopharmaceutical landscape with the rapid growth of antibody-drug conjugates and identifying the key lessons that can be applied across modalities
- Debating whether radiopharmraceuticals are approaching a similar inflection point to ADCs and what challenges still need to be overcome to unlock broader adoption
